Channels - Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis :: FRELIP Discovery

Similar Items: Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis

Quick Look
Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category
Quick Look
Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A critical appraisal
Quick Look
Real-World Effectiveness of Tirzepatide in Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study
Quick Look
Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney disease
Quick Look
Optimizing Type 2 Diabetes Management in Iraq: Expert Consensus on Initiation and Intensification of Insulin-Based Treatment Options
Quick Look
Association Between Anthropometric Indices and Presence of Type 2 Diabetes Mellitus in Obesity
Quick Look
Prevalence and Risk Factors for Iron Deficiency Anemia in Patients With Type 2 Diabetes in Jordan
Quick Look
Comparison of Ideal vs. Actual Body Weight Dosing of Intravenous Immunoglobulins for Immune Thrombocytopenia: A Retrospective Analysis
Quick Look
Physiological phenotypes of obstructive sleep apnea identified by cluster analysis: Association with type 2 diabetes
Quick Look
Persistence-Dependent Effectiveness of Tirzepatide on the Cardio-Metabolic-Kidney Syndrome Outcomes in Obesity: Real-World Evidence from the United Arab Emirates
Quick Look
Biological and Social Risk Factors for Predicting Type 2 Diabetes in Youth with Prediabetes: Review of Existing Prediction Models
Quick Look
Polygenic risk score refines cardiovascular disease risk in individuals with type 2 diabetes at borderline or intermediate risk
Quick Look
Association between thyroid dysfunction and cognitive impairment in type 2 diabetes mellitus: A cross‐sectional study
Quick Look
Efficacy and Safety of Insulin Efsitora Versus Degludec in Adults with Type 2 Diabetes Who Are Insulin-Naïve: Japan Subgroup Analysis of QWINT-2
Quick Look
Podcast Episode 3: How Can Physicians Work Collaboratively to Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes?
Quick Look
The effect of linoderm ointment, containing evening primrose oil, phonophoresis on symptoms of peripheral neuropathy in patients with type 2 diabetes
Quick Look
Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis
Quick Look
Correspondence: Effects of short‐term tofogliflozin treatment on insulin secretory capacity in type 2 diabetes: Insights and future directions
Quick Look
Identification of Patient Clusters with Distinct Disease Progression Patterns Utilizing a Nationwide Finnish Population with Type 2 Diabetes
Quick Look
Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
Quick Look
Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study
Quick Look
Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients with Diabetes Mellitus Following Heart Transplantation: A Meta-analysis
Quick Look
Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
Quick Look
Life‐threatening acute complications persist among individuals with type 1 diabetes in Japan: A nationwide registry‐based cross‐sectional study